Ukraine continues to implement digital technologies that enable the early detection of chronic diseases. The startup CheckEye uses artificial intelligence (AI) algorithms to screen the condition of the retina and diagnose diabetic retinopathy, a complication of diabetes that can lead to vision loss. The procedure takes just a few minutes: a medical professional photographs the fundus with a regular camera without the need to dilate the pupil. The image is uploaded to the platform, and the algorithm analyses it and within a few tens of seconds forms a conclusion about the presence of signs of retinopathy. According to research, CheckEye demonstrates 93% sensitivity and 86–93% specificity in detecting pathology.
The technology is already being used in medical institutions throughout Ukraine. Pilot projects have covered both large cities and regions where the population has limited access to specialised ophthalmology clinics. Thanks to the scalability of the solution, the approach to vision care is changing — from reactive medicine to preventive diagnostics. This allows many people to receive timely recommendations to see an ophthalmologist and prevent the progression of the disease.
In addition to diabetic retinopathy, the CheckEye team plans to expand the range of diagnosed diseases, including arterial hypertension and vascular or neurodegenerative diseases. In this way, the Ukrainian solution can make digital screening accessible and effective for a wide range of people — even in the least medically covered regions.
Read also:
“AI slop” was named word of the year for 2025 by Macquarie Dictionary
